Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.44%) to 7595.48, DAX +0.25% to 16963.83, CAC40 +0.71% to 7665.63, STOXX 600 (0.07%) to 485.27

Feb 08 ,2024

  • Synopsis:

    • European equity markets closed mixed to higher, with pan-European indices fluctuating in a relatively narrow range either side of unchanged through much of the session, before moving to new lows in late trading.

    • Ireland +1.8%, Netherlands +1.6% and Belgium +1.1% lead outperformers, whilst Portugal (1.1%), Denmark, Norway both (1.0%) lead underperformers

    • Focus was on central banker commentary and the prospect for future interest rate cuts as well as the slew of company earnings. Also the war in Ukraine, Israel's Binyamin Netanyahu rejection of a ceasefire with Hamas and the overnight US strike in Iraq receiving a "furious response" provided geopolitical backdrop

    • Riksbank's Jansson delivered a lecture on the economic situation and current monetary policy at a meeting arranged by Nordea. The Deputy Governor stated that with inflationary pressures having continued to ease, a rate cut in H1 of the year is a possibility.

    • National Bank of Belgium's Wunsch spoke at event organised by Bruegel think tank. BOE's Mann spoke at event organised by OMFIF 'Inflation Dynamics and drivers: looking under the bonnet'. ECB's Lane was involved in a fire-side chat at the Brookings Institution and ECB's Elderson was a panelist at joint ISPT and Port of Rotterdam Conf '24 "Material change". Bank of Latvia's Krasovska participates in the "Fintech Day" 2024 in Vilnius.

    • ECB published its latest economic bulletin

    • Central banks in Serbia and Czech Republic announced policy decisions, with the latter cutting its benchmark interest rate by more than expected. Governor Michl commented at the post decision press conf. that

    • The limited economic data releases included Netherlands final Jan CPI and Denmark Dec trade balance. In the UK, Recruitment and Employee Confederation (REC) published its latest Report on Jobs and the Royal Institution of Chartered Surveyors (RICS) its latest Residential Survey

    • Latest EU Parliament plenary session concludes today. In a debate with Commissioner Johansson, MEPs will outline their expectations for the upcoming meeting of the WTO's highest governing body from 26/29-Feb. Also voted on a resolution about tackling Russian attempts to interfere in the EU's democratic processes

    • The 27 EU governments due to vote on a historic overhaul of the EU's border and migration rules (Politico). Chancellor Scholz arrives in USA today and will meet U.S. lawmakers for dinner at the German ambassador's residence in Washington DC before tomorrow's meeting with President Biden

    • With the war in Ukraine now in its 715th day, sources in the German government said it was examining the possibility of nationalising Russian oil company Rosneft's operations in Germany. Whilst on Gaza, it's Health Ministry says the death toll from Israel's aggression on the blockaded territory has risen to 27,840 Palestinians killed since 7-Oct

    • Among the regions leading companies with earnings/update that weren't among the significant movers were ArcelorMittal (MT.NA) reports Q4 EBITDA $1.27B vs consensus $1.20B, raises dividend ~ +14% y/y and guides FY24, Siemens (SIE.GR) reports Q1 EPS pre-PPA €3.19 vs consensus €2.32, Societe Generale (GLE.FP) reports Q4 net income €430M vs StreetAccount €391.0M, expects FY24 revenue growth at or above +5% y/y and Unilever (ULVR.LN) reports FY underlying EPS €2.60 vs consensus €2.61, announces new share buyback program of up to €1.5B to be conducted during 2024.

    • The limited M&A news flow included Mondi shares closed down (3.2%) after confirms that it is in the early stages of considering a possible all share combination with DS Smith. Reportedly, Italian Treasury considering selling further 8-10% stake in Monte Paschi (BMPS.IM) and Moratti family approached by potential buyers of stake in Saras (SRS.IM)

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Persnl & HHold Goods +1.91%, Autos & Parts +1.49%, Ind Goods & Svcs +0.89%, Technology +0.88%, Media +0.52%, Financial Svcs +0.50%, Travel & Leisure +0.47%, Retail +0.03%

      • Underperformers:

        • Health Care (1.92%), Utilities (1.17%), Insurance (0.88%), Chemicals (0.69%), Banks (0.56%), Basic Resources (0.39%), Real Estate (0.38%), Oil & Gas (0.36%), Food & Beverage (0.32%), Telecom (0.25%), Construct & Mtls (0.22%)

    • Macro/Peripheral markets:

      • Interest rate decisions

        • Serbia unchanged at 6.5%, as expected; motivated by the continued subsiding of global inflationary pressures, the established downward trajectory of inflation at home and its anticipated retreat within the target tolerance band in mid-2024 - release

        • Czech Republic cut benchmark interest rate by a more than expected (50bps) to 6.25% - press release; presentation

      • ECB:

        • Economic Bulletin

        • National Bank of Belgium's Wunsch says pay growth is holding up easing by ECB, though the ECB will likely need to act on rates before it's fully comfortable with wage dynamics - Bloomberg

      • EU:

        • EU's von der Leyen speech at the roundtable meeting on green hydrogen

      • Finland:

        • Finland's next president will be a pro-European globalist - Reuters

        • Government has decided that the border crossing points on the land border between Finland and Russia will remain closed until 14-Apr-24 - release

      • Germany:

        • Coalition divided and already looking ahead to next election - Handelsblatt

      • Ireland:

        • EY forecasts Irish GDP 2024 +2.2% and 2025 +3.8%; Modified Domestic Demand 2024 +2.2% and 2025 +2.5% - release

        • Sinn Féin 28% (6), Fianna Fáil 20% unch, Fine Gael 19% +1 - B&A poll/Irish Times

      • UK:

        • Job recruiters report sharp slowdown in pay for new hires in Jan; Permanent placements fell at a sharp and accelerated pace, while the downturn in temp billings remained mild. Overall vacancies meanwhile declined slightly for the fourth time in five months - Recruitment and Employee Confederation (REC)

        • Jan house price balance (18%) vs consensus (25%) and prior revised (29%) from (30%); Further recovery for UK Residential sector expected in 2024 - RICS

        • CBI CEO speaks at LEAD 2024 conf; warns against 'large scale tax cuts driven by short-termism' - release

        • Labour ditches £28B green investment pledge - BBC

    • Company news:

      • Notable Gainers

        • +21.3% ADYEN.NA (Adyen) -- H2 net income €416M vs FactSet €336.1M [11 est, €255.6-379M]

        • +17.8% VBK.GR (Verbio) -- H1 EBITDA €74.9M vs year-ago €170.3M, guides FY EBITDA in the range of €120-150M vs FactSet €161.7M

        • +14.9% HAUTO.NO (Höegh Autoliners) -- Q4 EPS $1.03 vs year-ago $0.75, expects to transport lower volumes for Q1 than the average for the last quarters; January 2024 trading update

        • +14.0% NEWA.B.SS (New Wave Group) -- Q4 EPS SEK2.76 vs FactSet SEK2.66 [3 est, SEK2.50-2.85]

        • +13.0% AMBEA.SS (Ambea) -- Q4 EPS SEK1.48 vs year-ago SEK0.24; to launch a share buyback to repurchase 3M shares

        • +11.8% BAR.BB (Barco) -- FY net income €80.2M vs FactSet €88.8M [6 est, €82-96M]; downgraded to accumulate from buy at KBC

        • +10.7% MIPS.SS (MIPS) -- Q4 EPS SEK0.60 vs FactSet SEK0.90 [6 est, SEK0.70-1.24]

        • +10.1% FING.B.SS (Fingerprint Cards) -- Q4 EPS (SEK0.22) vs year-ago (SEK1.48)

        • +10.0% SF.SS (Stillfront Group) -- upgraded to buy from hold at Kepler Cheuvreux

        • +9.8% SMDS.LN (DS Smith)

          • receives highly preliminary expression of interest from Mondi

          • Mondi (MNDI.LN) confirms that it is in the early stages of considering a possible all share combination with DS Smith

        • +9.7% MTG.B.SS (Modern Times Group MTG)

          • Q4 EPS (SEK0.91) and unclear if comparable to FactSet SEK1.21 [3 est, SEK0.32-1.90]

          • combines Kongregate with Monumental for a 30% stake in the joined entity

        • +8.3% VEI.NO (Veidekke) -- Q4 EPS NOK3.50 vs FactSet NOK2.47 [3 est, NOK2.38-2.56]

        • +8.1% ALK.B.DC (ALK-Abello) -- Q4 net income DKK140M vs FactSet DKK157.4M [5 est, DKK140-182M], provides 2024 outlook

        • +7.6% HUH1V.FH (Huhtamaki) -- Q4 EPS €0.68 vs FactSet €0.60 [8 est, €0.48-0.74]

        • +7.4% SIGHT.FP (GenSight Biologics) -- completes €5.0M capital increase subscribed by existing shareholders

        • +7.4% RECSI.NO (REC Silicon) -- Q4 EPS $0.25; Reaffirms first delivery from Moses Lake in Q1 in 2024

        • +7.1% BATS.LN (British American Tobacco) -- FY Adj EPS 375.6p vs consensus 376.3p; continues to pursue all opportunities to enhance balance sheet flexibility and, as part of this, regularly reviews stake in ITC

        • +7.0% NEM.GR (Nemetschek) -- preliminary FY EBITDA €257.7M vs FactSet €255.3M [18 est, €234-279.1M]

        • +7.0% ONTEX.BB (Ontex Group) -- Q4 operating income €23.5M vs year-ago €11.7M

        • +6.5% NOD.NO (Nordic Semiconductor) -- upgraded to neutral from sell at UBS; to equal weight from underweight at Barclays

        • +6.3% GN.DC (GN Store Nord) -- Q4 Adj. EPS DKK2.86 vs year-ago DKK3.92

        • +6.3% OUT1V.FH (Outokumpu) -- Q4 EPS (€0.51) vs consensus €0.00

        • +6.2% KBC.BB (KBC Group) -- Q4 net result €677M vs consensus €686.9M

        • +5.5% KER.FP (Kering) -- FY recurring net income €3.06B vs consensus €3.17B, guides H1 of 2024

        • +5.2% SOI.FP (SOITEC) -- Q3 revenue €240M vs FactSet €269.5M [2 est, €244-295M], now guides FY revenue down ~ (10%) y/y; announces $2.1B revenue ambition initially modeled for FY26, will be postponed by around one year due to a weaker smartphone market

          • On earnings/updates: URW.FP (Unibail-Rodamco-Westfield), BOL.SS (Boliden), COOR.SS (Coor Service Management Holding), CPG.LN (Compass Group), ULVR.LN (Unilever), MT.NA (ArcelorMittal), BUFAB.SS (Bufab), ATT.SS (Attendo), AVON.LN (Avon Protection), FLOW.NA (Flow Traders), NSKOG.NO (Norske Skog), SAMPO.FH (Sampo), MYCR.SS (Mycronic), ACTI.SS (Active Biotech), INWI.SS (Inwido), NANO.LN (Nanoco Group), PNDX.B.SS (Pandox), BOOZT.SS (Boozt Fashion), SOLAR.B.DC (Solar), ORX.SS (Orexo), RNO.FP (Renault), DNO.NO (DNO), SIE.GR (Siemens), PUB.FP (Publicis Groupe), AIR.FP (Airbus), BFF Bank (BFF.IM), BMED.IM (Banca Mediolanum), ETTE.FH (Etteplan), STLAM.IM (Stellantis), ENT.LN (Entain) and reversing initial falls SRBNK.NO (Sparebank 1 SR-Bank), DB1.GR (Deutsche Börse),

      • Notable Decliners

        • -19.4% XXL.NO (XXL) -- Q4 adjusted net income (NOK441M) vs FactSet (NOK134.7M)

        • -14.7% MAERSK.B.DC (Maersk)

          • Q4 Underlying net income ($442M) vs consensus ($593.0M); to immediately suspend the share buy-back program

          • initiates demerger and separate listing of its towage and marine services activities in Svitzer; expected first day of trading is on 30-Apr

        • -12.3% NESTE.FH (Neste) -- Q4 EPS €0.66 vs consensus €0.63

        • -11.8% FSJ.LN (James Fisher & Sons) -- FY trading update: overall underlying trading in H2 in line with market expectations

        • -9.3% RUG.SS (Rugvista Group) -- Q4 EPS SEK1.17 vs FactSet SEK1.34 [2 est, SEK1.30-1.38]

        • -8.9% KWS.GR (KWS Saat) -- H1 EPS (€3.30) vs year-ago (€2.41); forecasts for FY23/2024 confirmed

        • -8.5% SOBI.SS (Swedish Orphan Biovitrum) -- Q4 Adj. EPS SEK3.21 vs FactSet SEK3.98 [7 est, SEK3.37-5.79]; guides 2024 revenue to grow by a high single-digit percentage at CER

        • -8.5% DNORD.DC (D/S Norden) -- FY EPS $12.3 vs FactSet $12.44 [2 est, $12.03-12.85], guides 2024 net income $150-250M vs FactSet $250M [2 est, $221-279M], initiates ~DKK105M (~$15M) share buy-back program

        • -7.2% ATEA.NO (Atea) -- Q4 EPS NOK2.22 vs FactSet NOK2.93 [7 est, NOK2.80-3.10]

        • -6.7% IBT.B.SS (Infant Bacterial Therapeutics) -- Q4 EPS (SEK3.04) vs year-ago (SEK3.57)

        • -6.7% ORK.NO (Orkla) -- Q4 Adjusted EPS NOK1.31 vs FactSet NOK1.45 [9 est, NOK1.34-1.58]

        • -6.1% AZN.LN (AstraZeneca) -- Q4 core EPS $1.45 vs consensus $1.50, issues FY24 guidance

        • -6.0% HUM.SS (Humana) -- Q4 net income SEK8M vs FactSet SEK26.7M [3 est, SEK1-42M]

        • -5.6% ELK.NO (Elkem) -- Q4 EPS (NOK0.73) vs year-ago NOK1.41

        • -5.5% ACA.FP (Credit Agricole) -- Q4 underlying net income €1.30B vs consensus €1.28B; raises dividend +24% y/y

        • -5.5% AKSO.NO (Aker Solutions) -- Q4 Adjusted EBITDA NOK615M vs FactSet NOK455.5M [12 est, NOK293.7-644M], guides 2024 revenue ~+15% y/y, EBITDA margins, excluding net income from the OneSubsea JV, to increase significantly y/y

        • -5.0% XANO.B.SS (XANO Industri) -- Q4 EPS SEK0.30 vs year-ago SEK0.40

        • -4.8% VONN.SW (Vontobel Holding) -- FY EPS CHF3.75 vs FactSet CHF3.93 [5 est, CHF3.29-4.43], announces additional cost cuts; agrees to acquire a significant minority stake in Ancala Partners LLP

        • -4.6% BRNK.GR (Branicks Group) -- downgraded to reduce from hold at Kepler Cheuvreux

        • -4.5% SSE.LN (SSE) --Q3 Trading Statement: Reaffirms FY24 adjusted EPS guidance, lower than planned Q3 renewables output narrows range of probable financial outcomes

          • On earnings/updates: IPN.FP (Ipsen), BPE.IM (BPER Banca), AKRBP.NO (Aker BP), PCELL.SS (PowerCell Sweden), MAREL.IR (Marel), SLIGR.NA (Sligro Food Group), GET.FP (Getlink), SPSN.SW (Swiss Prime Site), SCMN.SW (Swisscom), TLX.GR (Talanx), ANIM.IM (Anima Holding), WAGA.FP (Waga Energy), IPN.FP (Ipsen), AKTIA.FH (Aktia Bank), WALL.B.SS (Wallenstam), FPAR.A.SS (Fastpartner), BGN.IM (Banca Generali) and reversing initial gains WSU.GR (Washtec), WOSG.LN (Watches of Switzerland Group), ALMB.DC (Alm. Brand), LMN.SW (lastminute.com), DG.FP (VINCI), ALD.FP (Ayvens), BCVN.SW (Banque Cantonale Vaudoise), SVIK.SS (Studsvik), AAL.LN (Anglo American)

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Aperam (APAM.NA), NX Filtration (NXFIL.NA), Orange Belgium (OBEL.BB)

        • DACHs: EMS-Chemie (EMSN.SW), ams-OSRAM (AMS.SW), Mobimo (MOBN.SW), CECONOMY (CEC.GR), Carl Zeiss Meditec (AFX.GR), All for One Group (A1OS.GR), Fabasoft (FAA.GR)

        • Denmark: Coloplast (COLO.B.DC), DFDS (DFDS.DC)

        • Finland: Kemira (KEMIRA.FH), Enento (ENETO.FH), Stockmann (STOCKA.FH), YIT Oyj (YIT.FH), Lassila & Tikanoja (LAT1V.FH), Remedy Entertainment (REMEDY.FH), Digia (DIGIA.FH), HKScan (HKSAV.FH), Teleste Corp. (TLT1V.FH)

        • France: Hermes (RMS.FP)

        • Norway: Kongsberg Gruppen (KOG.NO), Yara International (YAR.NO), Entra (ENTRA.NO), Arendals Fossekompani (AFK.NO), ABG Sundal Collier (ABG.NO), Hofseth Biocare (HBC.NO)

        • Sweden: Saab (SAAB.B.SS), Fastighets AB Balder (BALD.B.SS), Skanska (SKA.B.SS), Sweco (SWEC.B.SS), Thule (THULE.SS), Medicover (MCOV.B.SS), Troax (TROAX.SS), Sdiptech (SDIP.B.SS), Volati (VOLO.SS), MedCap (MCAP.SS), Duni (DUNI.SS), Bergman & Beving (BERG.B.SS), Hexatronic (HTRO.SS), Scandi Standard (SCST.SS), Traction (TRAC.B.SS), Catella (CAT.B.SS), Exsitec (EXS.SS), Svedbergs (SVED.B.SS), Dedicare (DEDI.SS), Nilarngruppen (NIL.B.SS), Ascelia Pharma (ACE.SS)

        • Southern Europe: Mediobanca Banca di Credito Finanziario (MB.IM), illimity Bank (ILTY.IM), Banca Sistema (BST.IM), Iveco Group (IVG.IM)

      • Trading Update: Bellway (BWY.LN)

  • Data:

    • Economics:

      • Netherlands Jan CPI +3.2% y/y vs preliminary +3.2%

      • Denmark Dec trade balance DKK32.8B vs consensus DKK19.0B, prior revised DKK27.7B from DKK26.2B

    • Markets:

      • WTI Crude (Mar 24): +$1.89 or +2.56% to $75.75

      • €-$ (0.0008) or (0.07%) to 1.0765

      • £-$ (0.0017) or (0.13%) to 1.2612

      • €-£ +0.0006 to 0.8536

      • S&P 500 (0.12%)

      • Performance year-to-date:

        • FTSE 100: (1.78%)

        • DAX: +1.27%

        • CAC: +1.62%

        • MIB: +2.35%

        • Stoxx 600: +1.31%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE